Atrial Fibrillation Rate or rhythm control? Who should be anticoagulated? Other treatment strategies.

Slides:



Advertisements
Similar presentations
Atrial Fibrillation: Clinical Significance, Mechanisms, and Treatments
Advertisements

Atrial Fibrillation Cardiovascular ISCEE 26th October 2010.
New Atrial Fibrillation/Flutter Pathway and GRASP Tool
Catheter Ablation in the Treatment of Atrial Fibrillation
Atrial fibrillation Cardiology #2 Gimadeeva A.D..
Cardiovascular 2 Phase 2 Michelle Mair
{ Cardioversion turns 50 Seth Bilazarian MD Private practice theheart.org.
Ali Alsayegh, MD, FRCPC,FACC Consultant Cardiologist, Consultant Cardiac Electrophysiologist.
RATE CONTROL V/S RHYTHM CONTROL IN AF
ARRHYTHMIAS TACHYCARDIA>100/min BRADYCARDIA
Management of Supraventricular Tachycardias
Atrial fibrillation.
ATRIAL FIBRILLATION Linda A. Snyder, MSN, CRNP. Definition: A common arrhythmia characterized by chaotic, rapid, discontinuous atrial depolarizations.
Atrial Fibrillation Update 2012 Dr C Seifer Section of Cardiology St Boniface Hospital.
Atrial Flutter Chris Caulfield AM Report 2/19/10.
Atrial fibrillation wavelets propagating in different directions disorganised atrial depolarisation without effective atrial contraction f waves
Atrial fibrillation Daniel Gutenberger M.D. Chief Medical Director American General, Milwaukee.
Arrhythmias: The Good, the Bad and the Ugly
1 Clinical Overview of Atrial Fibrillation Edward L.C. Pritchett, M.D. Consulting Professor of Medicine Divisions of Cardiology and Clinical Pharmacology.
Atrial Fibrillation. Outline Epidemiology Signs and Symptoms Etiology Differential Diagnosis Diagnostic Tests Classification Management.
Atrial Fibrillation Steve McGlynn
Atrial Fibrillation Steve McGlynn Specialist Principal Pharmacist (Cardiology), Greater Glasgow and Clyde Honorary Clinical Lecture, University of Strathclyde.
NILOFAR RAHMAN, MD AMIT KUMAR, MD. DEFINITION  A SVT with uncoordinated atrial activation with constant deterioration of atrial mechanical function 
Cardioversion of Atrial Fibrillation Clinical Issues Christopher Granger, MD Director, Cardiac Care Unit Duke University Medical Center December 2007.
Arrhythmias Danny Haywood FY1.
Atrial Fibrillation. Statistics 1.5% of people over 65 have AF 1.5% of people over 65 have AF 5x increased risk of stroke 5x increased risk of stroke.
Clinical Title Date Jaret Tyler, MD Clinical Cardiac Electrophysiologist Assistant Professor of Medicine Ohio State’s Heart and Vascular Center Atrial.
Treating Atrial Fibrillation Richard Schilling St Bartholomew's Hospital, Queen Mary’s University of London.
Audit of ablation procedures for AF Barts and The London.
Arrhythmias Principles of long and short term management of arrythmias.
Samer Nasr, M.D. Mount Lebanon Hospital..  Lone atrial fibrillation:  Younger than 60 years old.  No clinical or echo evidence of cardiopulmonary.
Arrhythmia recognition and treatment
Sinus, Atrial, Junctional / Nodal, Ventricular, Blocks, others.
Cardioversion Curriculum. Learning Objectives At the conclusion of this activity, the learner will be able to: Identify appropriate.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Dr Avinash Haridas Pillai
West Herts Cardiology Arrhythmia Management Dr John Bayliss FRCP Consultant Cardiologist 17 Sept 2008.
European Heart Journal 2010 European Heart Rhythm Association (EHRA); Endorsed by the European Association for Cardio-Thoracic.
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Muhammad S Ajmal MBBS Aravind Herle MD FACC. Atrial fibrillation (AF) A supraventricular tachyarrhythmia characterized by uncoordinated atrial activation.
Perioperative management of atrial fibrillation
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Atrial Fibrillation Current Management Strategies.
Atrial Fibrillation What is New in the 2006 ACC/AHA/ESC Guidelines HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation. May 2007.
Atrial Fibrillation DR. DAYANAND NAIK, MD, FACC; CLINICAL ASSOCIATE PROFESSOR, NEW YORK MEDICAL COLLEGE.
MANAGEMENT OF ATRIAL FIBRILLATION VINOD G V. Definitions Paroxysmal AF - self-terminating, usually within 48 h, may continue for up to 7 days. Persistent.
Overview of the AFFIRM Study
#1009 Evaluation & Management of Atrial Fibrillation November 16 to 19 Stephen F. Schaal, MD Professor of Internal Medicine Division of Cardiology The.
AF: Catheter Ablation Isolation of the 4 pulmonary veins Linear lesions to create additional lines of block 1.
ATRIAL FIBRILLATION Dr ABHAY BAJPAI
Treatment of Atrial Fibrillation M Samson – PGY-2 Riverside Campus July 17, 2015 Academic Day.
1 AF: Issues with Anticoagulation AFL: Anticoagulation like AF When undergoing procedures with risk for bleeding: May DC warfarin for up to one week without.
Rhythm and Rate Control for Atrial Fibrillation Tom Wallace, MD Cardiac Electrophysiology CHI St. Vincent Heart Clinic Arkansas.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Palpitations & Atrial Fibrillation Dr Mehul B Dhinoja, Consultant Cardiologist & Electrophysiologist BMI The London Independent Hospital.
Atrial Fibrillation: An old age problem PCCS Village Hotel 18 th May 2011.
ARRHYTHMIAS Jamil Mayet. Arrhythmias - learning objectives –Mechanisms of action of antiarrhythmic drugs –Diagnosis To differentiate the different types.
Atrial Fibrillation Jay H. Lee, MD Denver Health Medical Center Wednesday 2 July 2008.
NR601-Primary Care of the Maturing and Aged Family Practicum
Atrial Fibrillation Rate vs Rhythm control
Atrial fibrillation J Heinsimer MD.
Zoll Firm Lecture Series
AF Basics for Office Visits Patient Education
Applied Therapeutics Dr. Riyadh Mustafa Al-Salih
Atrial fibrillation (AF) and flutter
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
Ann Parker Cardiology Pharmacist Frimley Health
Atrial Fibrillation: I’ve seen it all!
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
NICE 2014 Check pulse in patients presenting with:
Presentation transcript:

Atrial Fibrillation Rate or rhythm control? Who should be anticoagulated? Other treatment strategies

Classification: Aetiology LONE AF ALCOHOL RHEUMATIC HYPERTENSION HYPER THYROIDISM ISCHAEMIC ETC VS

Classification: FIRST EPISODE PERSISTENTPAROXYSMAL PERMANENT RECURRENT OR TimingAetiology LONE AF ALCOHOL RHEUMATIC HYPERTENSION HYPER THYROIDISM ISCHAEMIC ETC VS Circulation 2001;104:2118 –2150

Prevalence of AF: JAMA. 2001;285:

Mechanism of AF:

Burden of AF: AF 5% > 65 Fatigue Palpitations Syncope/Presyncope

Burden of AF: AF 5% > 65 Heart Failure Fatigue Stroke Palpitations Syncope/Presyncope Dyspnoea Oedema

Prognosis of AF: Circulation 1998;98:

Principles of management: 1.RESTORATION & MAINTENACE OF SINUS RHYTHM ‘Rhythm control’ 2.CONTROL OF VENTRICULAR RATE ‘Rate control’ 3.REDUCE THROMBOEMBOLIC RISK

Restoration of SR: RESTORATION OF SINUS RHYTHM ELECTRICAL 1) EXT DC SHOCK 2) INTERNAL SHOCK PHARMACOLOGICAL 1) FLECAINIDE: 2) PROPAFENONE 3) AMIODARONE 4) DOFETILIDE NB 60% REVERT SPONTANEOUSLY IN <24 HOURS

Restoration of SR: RESTORATION OF SINUS RHYTHM ELECTRICAL 1) EXT DC SHOCK 2) INTERNAL SHOCK PHARMACOLOGICAL 1) FLECAINIDE: 2) PROPAFENONE 3) AMIODARONE 4) DOFETILIDE NB 60% REVERT SPONTANEOUSLY IN <24 HOURS ANTICOAGULATION? HOW LONG IN AF? <48 HOURS NO HEPARIN 3 WEEKS WARFARIN POST SHOCK >48 HOURS 3 WEEKS WARFARIN PRE & POST SHOCK or TOE GUIDED SHOCK + 3 WEEKS WARFARIN POST SHOCK

Maintenance of SR (=prevention of AF recurrences): 1) DRUG TREATMENT:

Maintenance of SR (=prevention of AF recurrences): 2) OTHER TREATMENTS: Pacing Atrial Defibrillators Cardiac Surgery Catheter radiofrequency ablation

Rate control: VENTRICULAR RATE CONTROL PHARMACOLOGICAL 1) DIGOXIN 2)  BLOCKER 3) CA CHANNEL BLOCKER 4) AMIODARONE ABLATION RADIOFREQUENCY ABLATION OF ATRIOVENTRICULAR NODE + PACEMAKER

Rate vs rhythm control: Rate (Remain in AF):Rhythm (Restore SR): advantagesGood symptom control Simple low risk treatmentNormal physiology/cardiac function Better prognosis ?? disadvantages Abnormal cardiac functionComplex higher risk treatment Stroke risk ??Antiarrhythmic drugs - proarrhythmic Worse prognosis??

Rate vs rhythm control - PIAF: PIAF study Lancet 2000;356;

Rate vs rhythm control – AFFIRM: AFFIRM study - NASPE 2002 n = 4000  age = 70 Rate: Digoxin  Blocker Ca channel blocker Rhythm: Amiodarone Propafenone Sotalol +/- DC Cardioversion

Risk of Stroke? Optimal INR? 1 in 6 strokes have AF 6 x stroke rate if have AF TYPE OF AF IS NOT A RISK DETERMINANT

Who should be anticoagulated?